Latest hemophilia Stories
Data Demonstrate Therapeutic Levels of Clotting Factor for Hemophilia in Non-Human Primates and In Vivo Protein Production of Lysosomal Storage Disease Enzymes RICHMOND, Calif., Dec.
Twice-Weekly Prophylactic Regimen Resulted in 95% Reduction in Median Annualized Bleed Rate Compared to On-Demand Treatment SAN FRANCISCO, Dec.
PLAINSBORO, N.J., Dec.
Just Released Results from Innovaacom Program Show 94% of Physicians More Confident Treating and Communicating Best Practices for Hemophilia Atlanta, Georgia
FLINT, Mich., Nov. 4, 2014 /PRNewswire/ -- American Homecare Federation, a Diplomat company (NYSE: DPLO), is celebrating 25 years of business this year.
WEST LEBANON, N.H., Oct.
JNC is the Bleeding Disorders Community's Original Golf and Baseball Competition for Kids with Hemophilia and/or von Willebrand disease (VWD) and Their Families PHOENIX, Oct.
An Educational Program Based on the Findings From the Hemophilia Experiences, Results, and Opportunities (HERO) Study Launched at NHF's 66th Annual Meeting NEW YORK and PLAINSBORO,
National Hemophilia Foundation Encourages Patient Community to Take an Active Part in Strategies, Policies, and Programs Directly Affecting Their Lives at 66th Annual Meeting in Washington, DC
- Only Hemophilia A Therapy to Provide Bleeding Protection with Prophylactic Regimens of Either Every Three to Five Days or Once-Weekly Infusions - MISSISSAUGA, ON, Aug.
- totally perplexed and mixed up.